(Q33375771)

26 July 2017

1 reference

title

Clinical pharmacokinetics of carboplatin (English)

1 reference

26 July 2017

Clinical Pharmacokinetics of Carboplatin (English)

1 reference

10.2165/00003088-199121040-00002

Crossref

DOI

https://api.crossref.org/works/10.2165/00003088-199121040-00002

17 November 2022

1 reference

1 reference

1 reference

10.2165/00003088-199121040-00002

https://api.crossref.org/works/10.2165/00003088-199121040-00002

17 November 2022

author name string

van der Vijgh WJ

series ordinal

1

1 reference

26 July 2017

W. J. van der Vijgh

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1760899

17 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1760899

17 November 2022

publication date

1 October 1991

1 reference

Clinical Pharmacokinetics

26 July 2017

published in

1 reference

26 July 2017

volume

21

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

242-261

1 reference

Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding

26 July 2017

cites work

1 reference

12 December 2020

Phase I clinical trial and pharmacokinetics of carboplatin (NSC 241240) by single monthly 30-minute infusion

1 reference

12 December 2020

Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma.

1 reference

12 December 2020

Determination of platinum-containing drugs in human plasma by liquid chromatography with reductive electrochemical detection

1 reference

12 December 2020

Optimal dosing with carboplatin

1 reference

12 December 2020

Experimental and clinical results with intraperitoneal cisplatin.

1 reference

12 December 2020

Post-column reaction detector for platinum(II) antineoplastic agents

1 reference

12 December 2020

Pharmacokinetics of carboplatin after i.v. administration

1 reference

12 December 2020

An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin

1 reference

12 December 2020

Pentetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy

1 reference

12 December 2020

The determination of platinum in biological fluid by means of graphite furnace atomic absorption spectrometry

1 reference

12 December 2020

In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum(IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobu

1 reference

12 December 2020

In vitro stability, plasma protein binding and blood cell partitioning of 14C-carboplatin

1 reference

12 December 2020

Kinetics and mechanism of uptake of platinum-based pharmaceuticals by the rat small intestine

1 reference

12 December 2020

High-performance liquid chromatographic procedures for the analysis of carboplatin in human plasma and urine

1 reference

12 December 2020

Pharmacokinetics of platinum in cancer patients treated with carboplatin in combination with high-dose methotrexate

1 reference

12 December 2020

Human pharmacokinetics of carboplatin after oral administration

1 reference

12 December 2020

The disposition of carboplatin in the beagle dog

1 reference

12 December 2020

Pharmacokinetics of carboplatin after intraperitoneal administration

1 reference

12 December 2020

Direct analysis of platinum in plasma and urine by electrothermal atomic absorption spectrophotometry

1 reference

12 December 2020

Diethyldithiocarbamate modulation of murine bone marrow toxicity induced by cis-diammine(cyclobutanedicarboxylato)platinum (II)

1 reference

12 December 2020

Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin

1 reference

12 December 2020

On-line differential pulse polarographic detection of carboplatin in biological samples after chromatographic separation

1 reference

12 December 2020

Uptake of platinum compounds in human tumors. In vitro study.

1 reference

12 December 2020

Formation of interaction products of carboplatin with DNA in vitro and in cancer patients

1 reference

12 December 2020

Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy

1 reference

12 December 2020

Protein binding of five platinum compounds. Comparison of two ultrafiltration systems

1 reference

12 December 2020

The establishment, characterization and calibration of human ovarian carcinoma xenografts for the evaluation of novel platinum anticancer drugs

1 reference

12 December 2020

Comparative distribution and excretion of carboplatin and cisplatin in mice

1 reference

12 December 2020

Phase I study and pharmacokinetics of intraperitoneal carboplatin

1 reference

12 December 2020

The effect of diethyldithiocarbamate on the haematological toxicity and antitumour activity of carboplatin

1 reference

12 December 2020

Carboplatin substitution for cisplatin in the treatment of ovarian carcinoma--a word of caution

1 reference

12 December 2020

The comparative tissues distribution of platinum and 14C in mice receiving 14C-labelled carboplatin

1 reference

12 December 2020

Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function

1 reference

12 December 2020

Platinum levels in murine tumor following intraperitoneal administration of cisplatin or paraplatin

1 reference

12 December 2020

Interindividual human variation in cisplatinum sensitivity, predictable in an in vitro assay?

1 reference

12 December 2020

Carboplatin: current status and future prospects

1 reference

12 December 2020

Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin

1 reference

12 December 2020

Phase I studies with carboplatin at the Royal Marsden Hospital

1 reference

12 December 2020

Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive days

1 reference

12 December 2020

The pharmacology of carboplatin

1 reference

12 December 2020

Clinical pharmacokinetics of carboplatin

1 reference

12 December 2020

Serial determination of platinum, protein content and free sulfhydryl levels in plasma of patients treated with cisplatin or carboplatin.

1 reference

12 December 2020

Liquid chromatographic procedure for the quantitative analysis of carboplatin in beagle dog plasma ultrafiltrate

1 reference

12 December 2020

Prediction of hematologic toxicity of carboplatin by creatinine clearance rate

1 reference

12 December 2020

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.

1 reference

12 December 2020

Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin

1 reference

12 December 2020

Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions

1 reference

12 December 2020

Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin

1 reference

12 December 2020

Evaluation of reductive amperometric detection in the liquid chromatographic determination of antineoplastic platinum complexes

1 reference

12 December 2020

Determination of platinum in blood by adsorptive voltammetry

1 reference

12 December 2020

Preliminary observations of intraperitoneal carboplatin pharmacokinetics during a phase I study of the Northern California Oncology Group

1 reference

12 December 2020

Intraperitoneal therapy in the management of ovarian carcinoma

1 reference

12 December 2020

Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency

1 reference

12 December 2020

Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum

1 reference

12 December 2020

Phase I clinical and pharmacologic trial of carboplatin daily for 5 days

1 reference

12 December 2020

Complete remission of brain metastases of ovarian cancer following high-dose carboplatin: a case report and pharmacokinetic study

1 reference

12 December 2020

Whither the modulation of platinum?

1 reference

12 December 2020

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support

1 reference

12 December 2020

Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma.

1 reference

12 December 2020

Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of cisplatin

1 reference

12 December 2020

Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation

1 reference

12 December 2020

Trace analysis for cis-platinum anti-cancer drugs via LCEC.

1 reference

12 December 2020

The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats

1 reference

12 December 2020

Nonlinear renal clearance of ultrafilterable platinum in patients treated with cis-dichlorodiammineplatinum (II).

1 reference

12 December 2020

Anti-tumor effect of cisplatin, carboplatin, mitoxantrone, and doxorubicin on peritoneal tumor growth after intraperitoneal and intravenous chemotherapy: a comparative study

1 reference

12 December 2020

Discrepancy between cytotoxicity and DNA interstrand crosslinking of carboplatin and cisplatin in vivo

1 reference

12 December 2020

Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of aqua (1,1-bis(aminomethyl)cyclohexane) sulfatoplatinum (II) (spiroplatin) during a phase I trial

1 reference

12 December 2020

The disposition of carboplatin in ovarian cancer patients

1 reference

12 December 2020

Overview of carboplatin: replacing, complementing, and extending the therapeutic horizons of cisplatin

1 reference

12 December 2020

Phase I and pharmacokinetic trial of carboplatin in refractory adult leukemia

1 reference

12 December 2020

Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum(II) (CBDCA) in cancer patients

1 reference

12 December 2020

Pharmacokinetics of unchanged carboplatin (CBDCA) in patients with small cell lung carcinoma

1 reference

12 December 2020

A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposide

1 reference

12 December 2020

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

12 December 2020

Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles

1 reference

12 December 2020

Determination of carboplatin in canine plasma by liquid chromatography with ultraviolet-visible detection and confirmation by atomic absorption spectroscopy

1 reference

12 December 2020

High-dose carboplatin with diethyldithiocarbamate chemoprotection in treatment of women with relapsed ovarian cancer

1 reference

12 December 2020

Re: Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function

1 reference

12 December 2020

DNA adducts of cisplatin and carboplatin in tissues of cancer patients

1 reference

12 December 2020

Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function

1 reference

12 December 2020

Diethyldithiocarbamate inhibition of murine bone marrow toxicity caused by cis-diamminedichloroplatinum(II) or diammine-(1,1-cyclobutanedicarboxylato)platinum(II)

1 reference

12 December 2020

Evaluation of platinum-DNA adduct levels relative to known prognostic variables in a cohort of ovarian cancer patients

1 reference

12 December 2020

A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells

1 reference

12 December 2020

Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin

1 reference

12 December 2020

Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts

1 reference

12 December 2020

A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).

1 reference

12 December 2020

In vitro plasma binding of some second generation antitumor platinum complexes

1 reference

12 December 2020

Intraperitoneal carboplatin in the treatment of minimal residual ovarian cancer

1 reference

12 December 2020

Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer

1 reference

12 December 2020

Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.

1 reference

12 December 2020

Pharmacokinetics of ethylenediaminemalonatoplatinum(II) (JM-40) during phase I trial

1 reference

12 December 2020

Comparative pharmacokinetics of cisplatin and three analogues in mice and humans

1 reference

12 December 2020

Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretion

1 reference

12 December 2020

10.2165/00003088-199121040-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1047951045

0 references

1 reference